An ECG-based deep learning model effectively detected peripartum cardiomyopathy with an AUROC of 0.877, demonstrating its potential as a non-invasive screening tool.
Observational (n=58,687)
Yes
Does an ECG-based deep learning model accurately detect peripartum cardiomyopathy in pregnant and postpartum women?
An ECG-based deep learning model can effectively and non-invasively screen for peripartum cardiomyopathy, potentially reducing delayed diagnosis.
Effect estimate: AUROC 0.877
BACKGROUND: Peripartum cardiomyopathy (PPCM) is a fatal maternal complication, with left ventricular systolic dysfunction (LVSD; Left ventricular ejection fraction 45% or less) occurring at the end of pregnancy or in the months following delivery. The scarcity of screening tools for PPCM leads to a delayed diagnosis and increases its mortality and morbidity. We aim to evaluate an electrocardiogram (ECG)-deep learning model (DLM) for detecting cardiomyopathy in the peripartum period. METHODS: For the DLM development and internal performance test for detecting LVSD, we obtained a dataset of 122,733 ECG-echocardiography pairs from 58,530 male and female patients from two community hospitals. For the DLM external validation, this study included 271 ECG-echocardiography pairs (157 unique pregnant and postpartum period women) examined in the Ajou University Medical Center (AUMC) between January 2007 and May 2020. All included cases underwent an ECG within two weeks before or after the day of transthoracic echocardiography, which was performed within a month before delivery, or within five months after delivery. Based on the diagnostic criteria of PPCM, we analyzed the area under the receiver operating characteristic curve (AUROC), sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) to evaluate the model effectiveness. RESULTS: The ECG-based DLM detected PPCM with an AUROC of 0.877. Moreover, its sensitivity, specificity, PPV, and NPV for the detection of PPCM were 0.877, 0.833, 0.809, 0.352, and 0.975, respectively. CONCLUSIONS: An ECG-based DLM non-invasively and effectively detects cardiomyopathies occurring in the peripartum period and could be an ideal screening tool for PPCM.
Lee et al. (Wed,) conducted a observational in Peripartum cardiomyopathy (PPCM) (n=58,687). ECG-deep learning model (DLM) was evaluated on Detection of peripartum cardiomyopathy (AUROC 0.877). An ECG-based deep learning model effectively detected peripartum cardiomyopathy with an AUROC of 0.877, demonstrating its potential as a non-invasive screening tool.